Key facts
- This page summarizes Richard I. Steinhart's Form 4 filing for Actinium Pharmaceuticals, Inc. (ATNM).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Sep 2026, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
Footnote F2
The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.